InvestorsHub Logo
Followers 3
Posts 104
Boards Moderated 0
Alias Born 07/15/2016

Re: techxen post# 21605

Monday, 04/13/2020 11:56:29 AM

Monday, April 13, 2020 11:56:29 AM

Post# of 27409
techxen, US physicians have immediate access to research, just as you and I do. I was in a doc/GI specialist treatment room last year when I mentioned a drug he had not heard of. He was at his laptop taking notes during the exam, and immediately keyed in the drug, found studies, scanned them and got up to speed in three minutes, making a decision on treatment indications. All docs need is FDA approval to trigger them into action because finding answers to Covid 19 is that urgent. CytoSorb has some real advantages...no drug interactions, easy to implement, and effectiveness against cytokine storm. ICU docs will figure this out quickly with fast access to an abundance of research, based on scores of investigator studies and published papers all being available online. Besides, the safety of CytoSorb is well documented, too.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News